Clinical Outcomes for Glioblastoma Patients Requiring Invasive Mechanical Ventilation

Overview

This multicenter retrospective study analyzed 33 glioblastoma patients requiring invasive mechanical ventilation (IMV) in the ICU. The primary reasons for ICU admission were infections, status epilepticus, and elevated intracranial pressure, with a median time from diagnosis to ICU admission of 67 days. The study provides critical data on in-hospital mortality and survival outcomes to guide clinical decision-making.

Background

Glioblastoma is the most common primary malignant brain tumor with a median overall survival of 12 to 18 months despite multimodal therapy. Patients often require ICU admission due to complications such as brain edema, elevated intracranial pressure, seizures, or therapy-related infections. Data on outcomes for glioblastoma patients receiving invasive mechanical ventilation in the ICU are limited, complicating treatment guidance and goal reassessment. This study addresses the gap by focusing specifically on glioblastoma patients undergoing IMV in specialized neuro-oncological ICUs.

Data Highlights

Key Findings

• 33 glioblastoma patients requiring IMV were studied across four specialized centers.
• Mean age was 60.3 years; one-third were female.
• Median time from glioblastoma diagnosis to ICU admission was 67 days; 7 patients were diagnosed during ICU stay.
• Infections were the leading cause of ICU admission (34.3%), followed by status epilepticus (31.4%) and elevated intracranial pressure (22.9%).
• Some infections included opportunistic pathogens such as Pneumocystis jirovecii despite prophylactic antibiotics.
• Patients with newly diagnosed glioblastoma more frequently presented with elevated intracranial pressure requiring ICU care.

Clinical Implications

Clinicians should recognize that glioblastoma patients admitted to ICU with IMV often present with potentially reversible complications such as infections and seizures. Early identification and management of elevated intracranial pressure are critical, especially in newly diagnosed patients. These data support individualized ICU admission decisions and highlight the need for interdisciplinary neuro-oncological and intensive care collaboration.

Conclusion

This study provides valuable insights into the clinical characteristics and reasons for ICU admission in glioblastoma patients requiring invasive mechanical ventilation. The findings underscore the importance of tailored ICU management strategies to optimize outcomes in this vulnerable population.

References

1. Weller et al. 2015 -- Glioblastoma: Epidemiology and Treatment
2. Stupp et al. 2005 -- Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
3. Wick et al. 2017 -- Lomustine and Temozolomide in Glioblastoma
4. Kirson et al. 2007 -- Tumor Treating Fields
5. Englot et al. 2016 -- Seizures in Glioblastoma
6. Karnofsky and Burchenal 1949 -- Performance Status Scale
7. Schmidt et al. 2020 -- ICU Outcomes in Primary Brain Tumors